Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin D Horne

Showing results (91-100 of 282) with videos related to

Pageof 29
Sort By:
American Heart Journal|May 29, 2021
Simplifying the ISCHEMIA trial algorithm for clinical practice: Identifying left main coronary artery disease using coronary artery calcium scansJoel E Money, Joseph B Muhlestein, Steve Mason, et al.
American Journal of Nephrology|January 27, 2016
Novel Stratification of Mortality Risk by Kidney Disease StageAllen C Rassa, Benjamin D Horne, Raymond O McCubrey, et al.
Critical Pathways in Cardiology|December 3, 2009
Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiographyTroy E Madsen, Robert R Pearson, Joseph B Muhlestein, et al.
American Heart Journal|September 26, 2007
Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery diseaseBenjamin D Horne, Nicola J Camp, John F Carlquist, et al.
Lipids in Health and Disease|April 30, 2013
A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL₃+IDL])Heidi T May, John R Nelson, Krishnaji R Kulkarni, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Predicting postdischarge hospital-associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkersLindsey Snyder, Scott M Stevens, Masarret Fazili, et al.
The American Journal of Cardiology|January 16, 2007
Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of coronary arterial narrowingKent G Meredith, Benjamin D Horne, Robert R Pearson, et al.
Journal of the American College of Cardiology|May 22, 2007
Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery diseaseBenjamin D Horne, Nicola J Camp, Jeffrey L Anderson, et al.
Annals of Epidemiology|March 17, 2004
Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary diseaseBenjamin D Horne, Joseph B Muhlestein, Donald L Lappé, et al.
Journal of Thrombosis and Thrombolysis|May 26, 2010
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose predictionJohn F Carlquist, Benjamin D Horne, Chrissa Mower, et al.
Pageof 29

Showing results (91-100 of 282) with videos related to

Sort By:
Pageof 29
American Heart Journal|May 29, 2021
Simplifying the ISCHEMIA trial algorithm for clinical practice: Identifying left main coronary artery disease using coronary artery calcium scansJoel E Money, Joseph B Muhlestein, Steve Mason, et al.
American Journal of Nephrology|January 27, 2016
Novel Stratification of Mortality Risk by Kidney Disease StageAllen C Rassa, Benjamin D Horne, Raymond O McCubrey, et al.
Critical Pathways in Cardiology|December 3, 2009
Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiographyTroy E Madsen, Robert R Pearson, Joseph B Muhlestein, et al.
American Heart Journal|September 26, 2007
Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery diseaseBenjamin D Horne, Nicola J Camp, John F Carlquist, et al.
Lipids in Health and Disease|April 30, 2013
A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL₃+IDL])Heidi T May, John R Nelson, Krishnaji R Kulkarni, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Predicting postdischarge hospital-associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkersLindsey Snyder, Scott M Stevens, Masarret Fazili, et al.
The American Journal of Cardiology|January 16, 2007
Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of coronary arterial narrowingKent G Meredith, Benjamin D Horne, Robert R Pearson, et al.
Journal of the American College of Cardiology|May 22, 2007
Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery diseaseBenjamin D Horne, Nicola J Camp, Jeffrey L Anderson, et al.
Annals of Epidemiology|March 17, 2004
Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary diseaseBenjamin D Horne, Joseph B Muhlestein, Donald L Lappé, et al.
Journal of Thrombosis and Thrombolysis|May 26, 2010
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose predictionJohn F Carlquist, Benjamin D Horne, Chrissa Mower, et al.
Pageof 29